Gland Pharma IPO is going to hit the market on 9th November 2020. The company to raise around 6480 crore via IPO. The price band is fixed at 1490-1500 rupees with 10 shares of minimum bid. As per the price looks on a higher side. The company looks good as the GMP started in green but going down. Check out Gland Pharma IPO grey market premium, Kostak rates, and subject to sauda rates as of today.
Gland Pharma IPO GMP Rates day by day with Kotak rates.
- Grey market premium as on today is ā¹105-110, Kostak ā¹1000 & Subject to Sauda is ā¹N/A
- Grey market premium as on 19-11-2020 is ā¹105-110, Kostak ā¹1000 & Subject to Sauda is ā¹N/A
- Grey market premium as on 18-11-2020 is ā¹130-140, Kostak ā¹1000 & Subject to Sauda is ā¹N/A
- Grey market premium as on 17-11-2020 is ā¹05-10, Kostak ā¹N/A & Subject to Sauda is ā¹N/A
- Grey market premium as on 16-11-2020 is ā¹05-10, Kostak ā¹N/A & Subject to Sauda is ā¹N/A
- Grey market premium as on 15-11-2020 is ā¹05-10, Kostak ā¹N/A & Subject to Sauda is ā¹N/A
- Grey market premium as on 14-11-2020 is ā¹05-10, Kostak ā¹N/A & Subject to Sauda is ā¹N/A
- Grey market premium as on 13-11-2020 is ā¹05-10, Kostak ā¹N/A & Subject to Sauda is ā¹N/A
- Grey market premium as on 12-11-2020 is ā¹05-10, Kostak ā¹N/A & Subject to Sauda is ā¹N/A
- Grey market premium as on 11-11-2020 is ā¹20-25, Kostak ā¹200 & Subject to Sauda is ā¹N/A
- Grey market premium as on 10-11-2020 is ā¹20-25, Kostak ā¹200 & Subject to Sauda is ā¹N/A
- Grey market premium as on 09-11-2020 is ā¹40-45, Kostak ā¹300 & Subject to Sauda is ā¹2000
- Grey market premium as on 08-11-2020 is ā¹60-70, Kostak ā¹500 & Subject to Sauda is ā¹2000
- Grey market premium as on 07-11-2020 is ā¹60-70, Kostak ā¹500 & Subject to Sauda is ā¹2000
- Grey market premium as on 06-11-2020 is ā¹60-70, Kostak ā¹500 & Subject to Sauda is ā¹2000
- Grey market premium as on 05-11-2020 is ā¹70-80, Kostak ā¹500 & Subject to Sauda is ā¹1000
- Grey market premium as on 04-11-2020 is ā¹150-160, Kostak ā¹800 & Subject to Sauda is ā¹1400
- Grey market premium as on 03-11-2020 is ā¹200, Kostak ā¹1250 & Subject to Sauda is ā¹N/A
- Grey market premium as on 02-11-2020 is ā¹200, Kostak ā¹1250 & Subject to Sauda is ā¹N/A
Gland Pharma IPO Dates & Price Band:
| IPO Open: | 09 November 2020 |
| IPO Close: | 11 November 2020 |
| IPO Size: | Approx ā¹6480 Crore (Approx) |
| Face Value: | ā¹1 Per Equity Share |
| Price Band: | ā¹1490 – ā¹1500 Per Share |
| Listing on: | BSE & NSE |
| Retail Portion: | 35% |
| Equity: | 43,196,968 Shares |
Gland Pharma IPO Market Lot:
| Lot Size: | Minimum 10 Shares & Maximum 130 Shares |
| Minimum Amount: | ā¹15,000 |
| Maximum Amount: | ā¹1,95,000 |
Gland Pharma IPO Allotment & Listing:
| Basis of Allotment: | 17 November 2020 |
| Refunds: | 18 November 2020 |
| Credit to Demat Account: | 19 November 2020 |
| Listing Date: | 20 November 2020 |
Disclaimer:
– IPO Grey Market Premium (IPO GMP) mention is valid for the specific date as mentioned in the header.
– We are not buying and selling IPO forms on IPO Grey Market.
– Kostak Rate is the premium one gets by selling his/her IPO application (in an off-market transaction) to someone else even before allotment or listing of the issue.
– Do not subscribe for IPO by just seeing premium Price as it may change anytime before listing. Subscribe only considering Fundamental of the companies
